Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma.

Saved in:
Bibliographic Details
Title: Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma.
Authors: Mahuron KM; Department of Surgery, University of California, San Francisco, San Francisco, California.; Department of Surgery, City of Hope National Medical Center, Duarte, California., Shahid O; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts.; Gene Lay Institute of Immunology and Inflammation at Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Sao P; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wu C; Department of Medicine, University of Arizona, Tucson, Arizona., Haugh AM; Department of Medicine, University of California, San Francisco, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Huppert LA; Department of Medicine, University of California, San Francisco, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Levine LS; Department of Medicine, University of California, San Francisco, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Lowe MM; Department of Dermatology, University of California, San Francisco, San Francisco, California., Alvarado M; Department of Surgery, University of California, San Francisco, San Francisco, California., Micu M; Department of Medicine, University of California, San Francisco, San Francisco, California., Tsai KK; Department of Medicine, University of California, San Francisco, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Chow M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Singer M; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts., Schenkel JM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sharpe AH; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts.; Gene Lay Institute of Immunology and Inflammation at Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Rosenblum MD; Department of Dermatology, University of California, San Francisco, San Francisco, California., Pauken KE; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Daud AI; Department of Medicine, University of California, San Francisco, San Francisco, California.
Source: Cancer research [Cancer Res] 2025 Apr 15; Vol. 85 (8), pp. 1424-1440.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-23-3918